Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation

Published:2013-09 Issue:10 Volume:62 Page:900-908
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Eikelboom John W.,Connolly Stuart J.,Hart Robert G.,Wallentin Lars,Reilly Paul,Oldgren Jonas,Yang Sean,Yusuf Salim

Funder

Boehringer-Ingelheim

AstraZeneca, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Pfizer, Janssen, and sanofi-aventis

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

2. Newly identified events in the RE-LY trial;Connolly;N Engl J Med,2010

3. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial;Eikelboom;Circulation,2011

4. Anticoagulant options–why the FDA approved a higher but not a lower dose of dabigatran;Beasley;N Engl J Med,2011

5. Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable;Connolly;Ann Intern Med,2011

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic Approaches;Canadian Journal of Cardiology;2024-07

2. A framework for managing severe DOAC-related bleeding: Recognize, Reverse, Resume, Reduce;Thrombosis Update;2024-06

3. Effectiveness of Novel Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis;Cureus;2024-05-30

4. Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis from the ENVISAGE-TAVI AF Trial;The American Journal of Cardiology;2023-12

5. Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS‐SPAF);Journal of Arrhythmia;2023-03-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3